Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease

IMPORTANCE: There is currently no consensus as to which biomarkers best predict longitudinal tau accumulation at different clinical stages of Alzheimer disease (AD). OBJECTIVE: To describe longitudinal [(18)F]RO948 tau positron emission tomography (PET) findings across the clinical continuum of AD a...

Descripción completa

Detalles Bibliográficos
Autores principales: Leuzy, Antoine, Smith, Ruben, Cullen, Nicholas C., Strandberg, Olof, Vogel, Jacob W., Binette, Alexa Pichet, Borroni, Edilio, Janelidze, Shorena, Ohlsson, Tomas, Jögi, Jonas, Ossenkoppele, Rik, Palmqvist, Sebastian, Mattsson-Carlgren, Niklas, Klein, Gregory, Stomrud, Erik, Hansson, Oskar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689441/
https://www.ncbi.nlm.nih.gov/pubmed/34928318
http://dx.doi.org/10.1001/jamaneurol.2021.4654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689441/
https://www.ncbi.nlm.nih.gov/pubmed/34928318
http://dx.doi.org/10.1001/jamaneurol.2021.4654

Ejemplares similares